Analyst firms · Morgan Stanley · SOPH
Morgan Stanley SOPH price target and rating history
SOPHiA GENETICS SA (SOPH) · Technology
Morgan Stanley rates SOPHiA GENETICS SA (SOPH) Equal-Weight with a $5 price target, as of its latest action on Aug 7, 2024. It has published 3 rating actions on SOPH since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Equal-Weight
- Price target
- $5
- Median target, all firms
- Too few
- Actions on SOPH
- 3
Morgan Stanley price target on SOPH
Every Morgan Stanley rating on SOPH
- Aug 7, 2024
- Feb 15, 2022
- Aug 17, 2021
Questions about Morgan Stanley and SOPH
- What is Morgan Stanley's price target for SOPH?
- Morgan Stanley's latest stated price target for SOPHiA GENETICS SA (SOPH) is $5, from its action on Aug 7, 2024.
- What is Morgan Stanley's rating on SOPH?
- Morgan Stanley rates SOPH Equal-Weight, a neutral rating, as of Aug 7, 2024.
- When did Morgan Stanley last change its view on SOPH?
- On Aug 7, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $10 to $5.
All Morgan Stanley ratingsSOPH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.